×

RNS Number : 5988T

Concepta PLC

09 January 2017

 

9 January 2017

Concepta plc ("Concepta" or "the Company")

Concepta achieves ISO13485 accreditation for its myLotus fertility product ahead of targeted commercial launch in the UK and Europe in H2 2017

Concepta plc (AIM:CPT), the UK healthcare company targeting the personalised mobile health market with a primary focus on women's fertility, is pleased to announce that it has achieved ISO13485 accreditation, a key step in attaining its CE marking for its 'myLotus' product for unexplained infertility*, ahead of a commercial launch in the UK and Europe in H2 2017.

The ISO13485 certification is an endorsement of the Quality Management System (QMS) that underpins the Company's position as a manufacturer of medical devices. The accreditation is recognised on an international scale and is a critical part of gaining regulatory approval for Concepta's myLotus to be sold in the European Union.

Commenting on the agreement, Erik Henau, CEO of Concepta said: "This is a proud moment for the Concepta team and importantly a crucial development towards the launch of our flagship myLotus fertility product into the UK and European markets, where the potential market opportunity is circa £350 million. 

"It cannot be underestimated how much work goes into documenting the procedures of an entire organisation within a QMS system and ensuring that the procedures are followed to the point that they become a seamless part of everyday operations. It is a strong endorsement of the quality of an organisation at all levels.

 "Further to this we are delighted to report that with regulatory approvals and manufacturing agreements already in place in China we remain on track to roll out the myLotus product into the Chinese market in H1 2017."

 

ENDS

 

 

Enquiries:

The Company

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

 

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: +44 (0)20 368 3550

 

Beaufort Securities Limited (Broker)

Jon Belliss

Tel: +44 (0)20 7382 8300

 

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess/ Francesca Hillier

Tel: +44 (0) 7748 843 871

 

About Concepta Plc:

Concepta plc is a pioneering UK healthcare company that has developed a proprietary platform and products targeted at the personalised mobile health market with a primary focus on women's fertility and specifically unexplained infertility*.

 

Founded in 2013, Concepta has developed a revolutionary flagship product 'myLotus' for home self-testing that helps women with unexplained infertility to conceive.  

 

myLotus is the only consumer product which allows both quantitative and qualitative measurements of measurement of a woman's personal hCG and LH hormone levels in an easy to use home test to facilitate higher conception rates and early diagnosis of any fertility problems.  Competitor products currently only allow qualitative measurement and are based on the 'average woman'.  

 

Concepta has a defined route to market for its new 'myLotus' product with Regulatory approvals for launch in China in place for 2016 and CE-Marking for UK and Europe to follow in 2017 where the revenue potential of the Chinese and EU infertility market is worth c.£600m per annum for the company.

 

*Unexplained infertility refers to women that have been unable to conceive after 6 months of trying. This highly motivated target group of consumers won't typically be offered medical intervention until 12 months of unsuccessfully trying, with IVF not offered until two years. Research indicates couples start to take positive action ahead of this time and there is little medical support to help them do so.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCOKFDKNBKDQDK

Close

×

RNS Number : 5969T

Cronin Group PLC

09 January 2017

 

9 January 2017

 

Cronin Group Plc

("Cronin" or the "Company")

 

DigitalGlassware™

 

Cronin Group Plc announces that between the 9th and 12th January 2017 Professor Lee Cronin, Founding Scientific Director, will be attending the 35th Annual J.P. Morgan Healthcare Conference and at which he will be introducing the Company's pathway to its first commercial product to a number of potential partners and key opinion leaders.

During 2017 Cronin Group intends to release prototype and beta versions of a new product platform, branded DigitalGlassware™, which it anticipates will undergo testing and development with a number of collaboration partners.   Early product releases of DigitalGlassware™ will be a low-cost, easy to use chemical telemetry product designed to enable the first digitization of chemistry in commercial and academic research laboratories.  Eventually the DigitalGlassware™ platform is envisaged to have a range of commercial applications in various target markets, including Healthcare.

Cronin Group's ultimate vision is to commercialise the Chemputer™, an autonomous universal digital synthesis engine, which intends to open up chemistry to a wider user-base via digitization. This will allow chemical synthesis to be flexible and widely accessible irrespective of access to physical infrastructure and chemical knowledge.

 

ENDS

 

 

Contacts:
Cronin Group Plc	www.croningroupplc.com
James Ede-Golightly, Chairman	T: 01481 701 564
WH Ireland Limited	www.wh-ireland.co.uk
Mike Coe / Ed Allsopp	T: 0117 945 3470

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCSSLFAMFWSEIF

Close

×

RNS Number : 2697T

Nanoco Group PLC

04 January 2017

 

For immediate release

4 January 2017

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company") 

 

Nanoco Fine Color Film™ TVs at CES

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, announces that three leading LCD television manufacturers are exhibiting televisions using Nanoco CFQD® Fine Color Film™ at this year's CES, the international consumer electronics show opening tomorrow in Las Vegas.

 

The three manufacturers, Hisense Electric Co Ltd ("Hisense"),TCL and TPV Philips ("TPV"), are all displaying large screen, ultra high definition, wide colour gamut LCD televisions at Nanoco's presentation and marketing suite at CES. The developmental televisions all use  CFQD® Fine Color Film™, the cadmium-free quantum dot film produced through Nanoco's commercial relationship with Taiwan's Wah Hong Industrial Corporation ("Wah Hong"). The film incorporates cadmium-free quantum dots produced at Nanoco's Runcorn production plant.

 

Hisense, TCL and TPV produce tens of millions of LCD TVs each year and have a major and growing presence in international LCD television markets.

 

The televisions will be on display at Nanoco's marketing suite at CES from 5-8 January 2017.

 

Michael Edelman, Nanoco's Chief Executive Officer, said: "We are delighted that Hisense, TCL and TPV are all displaying demonstrator LCD televisions at the Nanoco presentation suite at this year's CES. These demonstrator televisions reflect the high level of interest in our CFQD® Fine Color Film™ produced with our commercial partner Wah Hong. We are very pleased with the pace of commercialisation under the agreement with Wah Hong, which was signed in July last year."

 

 

For further information, please contact:

 

Nanoco	Tel: +44 (0) 161 603 7900
Michael Edelman, Chief Executive Officer
David Blain, Chief Financial Officer
Caroline Watson, Investor Relations Manager	Tel: + 44 (0) 7799 897357
cwatson@nanocotechnologies.com
Peel Hunt	Tel: +44 (0) 20 7418 8900
Adrian Trimmings
George Sellar
Buchanan	Tel: +44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Stephanie Watson

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCEAAFDEAFXEAF

Close

×

RNS Number : 6630S

EU Supply PLC

23 December 2016

 

23 December 2016

EU Supply plc

("EU Supply", the "Company" or the "Group")

 

Contract wins

 

EU Supply (LSE AIM: EUSP), the e-procurement software provider, is pleased to announce that it has entered into a contract for enhancements of its CTMTM platform with an existing customer in the UK.   

 

The enhancement contract is expected to generate revenues of approximately £100,000, including maintenance and support, with the project work commencing in December 2016 and is expected to be completed in the first half of 2017.

 

In addition, the Group has been awarded several new smaller contracts in Scandinavia.  Two of these contracts for EU Supply's CTMTM platform have been entered into with Verdo A/S, a leading European renewable energy group, and the Danish Ministry of Employment, which further consolidate the Group's strong market position in Denmark.

 

 

FURTHER ENQUIRIES

EU Supply PLC Tel: 020 7127 4545 Thomas Beergrehn, CEO   Mattias Ström, CFO       Stockdale Securities Tel: 020 7601 6100 Tom Griffiths, David Coaten

 

A copy of this announcement is available at www.eu-supply.com.

 

Notes to Editors

EU Supply is the UK holding company of the EU Supply Group, a Sweden-based e-commerce business, which has an established, market-leading, multilingual e-procurement platform for esourcing, e-tendering and contract management, tailored for the highly regulated European public sector market.

Since 2006, the Group has invested heavily in employing specialist programmers to add functionality, legal compliance as required and security features to its Complete Tender Management™ ("CTM™") platform to ensure that the Group is ideally placed to secure new contracts with EU Member States and their Contracting Authorities. The platform is available in 16 different languages.

The Directors believe that the Group's CTM™ platform is one of the easiest to use and most functionally advanced solutions available in the market. The CTM™ platform is used by over 7,000 European public sector bodies in 9 EU/EEC Member States and has National Procurement System status in four Member States (the UK, Ireland, Norway and Lithuania).

The Company's shares were admitted to trading on AIM in November 2013. In August and September 2015, the Company raised a total of £2.061m (before expenses) through a placing of new shares and the issue of first and second tranches of Convertible Loan Notes to institutional and other investors.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTBLBDDXUDBGLD

Close

×

RNS Number : 5455S

EVR Holdings PLC

22 December 2016

 

For Immediate Release                                                                                                                                22 December 2016

 

EVR Holdings plc

('EVR' or the 'Company')

 

Warner Music Inc. signs global VR content and distribution agreement with MelodyVR and simultaneously receives entitlement to subscribe for 43,239,926 million shares in EVRH at 4.25p per share

Agreement further strengthens EVR's position at the forefront of global virtual reality content creation

 

EVR Holdings plc (AIM: EVRH), a leading creator of virtual reality ('VR') music content, is pleased to announce that its subsidiary MelodyVR Ltd ('MelodyVR') has signed a VR content creation and distribution agreement with Warner Music Inc. and WEA International Inc. (collectively, 'Warner'). Warner, one of the three largest record companies in the world, reported digital sales in 2015 of US$1.24 billion and owns and operates a number of successful record labels including Atlantic Records, Parlophone Records and Warner Bros. Records.

 

The framework agreement is intended to facilitate the creation and distribution of Virtual Reality content featuring Warner artists. As part of the relationship, MelodyVR will receive the right to distribute both live and pre-recorded content created with Warner artists via its music platform for an exclusive period, followed by a period of joint-exploitation by both parties.

 

The Company is also pleased to announce that Warner Music Inc. will, in addition, receive an entitlement to subscribe for 43,239,926 ordinary £0.01 shares in EVR Holdings PLC, exercisable until the 5th anniversary of today's date, at an exercise price of 4.25p.

 

The content and distribution agreement will enhance Melody's distribution capabilities with respect to its extensive content library.

 

Anthony Matchett, CEO of EVR Holdings, said: "Entering into a framework agreement with one of the world's leading rights holders in music is a significant milestone for MelodyVR and I'm delighted to announce that we've signed a virtual reality creation and distribution agreement with Warner. The agreement aims to streamline the creation and distribution of virtual reality content featuring Warner artists and also unlocks a substantial portion of our existing content library for commercial exploitation. Warner Music represents a number of the world's most recognised artists and over the coming years we are looking forward to creating even more content with their outstanding roster of talent. We believe that Warner's request to subscribe for 43,239,926 shares shows both their confidence and conviction in the enormous potential of virtual reality as well as in the long-term success of EVR Holdings and the MelodyVR platform. We look forward to working even more closely with Warner Music moving forwards. "

 

– Ends –

 

For further information:

EVR Holdings plc
Sean Nicolson, Chairman	Tel: +44 (0) 20 7466 5000
Anthony Matchett, Chief Executive Officer	www.EVRHoldings.com
SPARK Advisory Partners Limited (Nominated Adviser)
Neil Baldwin / Sean Wyndham-Quin		Tel: +44 (0) 203 368 3550
		www.sparkadvisorypartners.com
Peterhouse Corporate Finance Limited (Broker)		Tel: +44 (0) 20 7469 0930
Eran Zucker / Lucy Williams		www.pcorpfin.com

 

Media enquiries:

Buchanan
Ben Romney / Jamie Hooper Stephanie Watson / Catriona Flint	Tel: +44 (0) 20 7466 5000
EVR@buchanan.uk.com	www.buchanan.uk.com

 

Notes to Editors:

 

MelodyVR

MelodyVR is a wholly owned subsidiary of EVR Holdings plc ('EVR'), a company that is listed on the AIM market of the London Stock Exchange under the ticker EVRH.L. EVR, a creator of virtual reality content, joined AIM on 16 May 2016 following a reverse takeover of Armstrong Ventures plc.

 

The Company has successfully built a VR content library of over 500 globally-renowned artists as well as having secured a number of long-term partnerships, obtaining exclusive recording rights for the creation and distribution of VR content across a total of 58 worldwide event properties and music venues. Further information can be viewed at www.evrholdings.com 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

AGRDGBDDSXDBGLB

Close

×

RNS Number : 6057S

EVR Holdings PLC

22 December 2016

 

For immediate release

22 December 2016

 

EVR Holdings plc

('EVR' or the 'Company')

 

MelodyVR announces launch of highly anticipated beta app on Christmas Eve

and the appointment of Nikki Lambert as Vice President, Marketing

 

EVR Holdings plc (AIM: EVRH), a leading creator of virtual reality content, is pleased to announce that its subsidiary MelodyVR Ltd ('MelodyVR') will launch a beta version of its music platform on 24  December 2016.

 

MelodyVR will launch a staged beta programme to a closed group of users who will experience advanced platform functionality and exclusive content, accessible via Samsung Gear VR devices, during the holiday period and beyond. The initial user group, comprising a broad range of geographies and demographics, aims to collect insights and data relating to how consumers interact with the music service.

 

With a number of new Virtual Reality ('VR') Head-Mounted Displays ('HMDs') released throughout October and November 2016, including PlayStation VR and Google Daydream, consumers are now enjoying even greater accessibility to VR devices and an ever broadening variety of VR experiences. Mark Zuckerberg announced on the 5 October 2016 at Oculus Connect 3 in San Jose, that the number of active Samsung Gear VR users has now hit 1,000,000 per month. The timing of MelodyVR's beta launch and choice of launch platform coincides with a period of unprecedented accessibility to VR headsets with consumer demand for VR music content reaching an all-time high.

 

The Company is also pleased to announce the appointment of Nikki Lambert, as VP of Marketing.  Nikki brings in-depth marketing knowledge, established through 15 years of creating and building global consumer brands in the technology and music space.  In her 10 years with the Virgin Group Nikki was instrumental in launching and managing multiple mobile, radio and festival businesses across Asia, Africa and Europe.  Prior to joining MelodyVR, Nikki spent five years working at Spotify. One of the first senior marketing hires into the organisation, Nikki led international marketing efforts, including launches in Germany, Indonesia and Japan in parallel with growing the brand and subscriber base in wider Europe, Spotify's most mature region.

 

In this newly created role, Nikki will report to Anthony Matchett, building and leading the marketing organization. Responsible for strategic and operational marketing efforts and launch activities for the company, Nikki will also drive brand development and all consumer insight efforts, including management of the beta programme.

 

Speaking about the upcoming launch, Anthony Matchett, CEO of EVR Holdings, said: "Following on from the overwhelming success of our partnership with Telefonica, we are delighted to announce the upcoming launch of our beta programme and the appointment of Nikki Lambert as VP of Marketing. The 2016 holiday season is a time of particular interest to our company and we look forward to seeing increased user adoption and market penetration of virtual reality devices throughout this period and beyond. On the 24 December 2016, we will launch a staged beta programme reaching up to one thousand initial users throughout Europe and the USA. The programme, managed internally and available to select Samsung Gear VR users via Oculus home, will enable our company to harness data and feedback regarding user interaction and content preferences as consumers utilise their VR devices throughout the holiday period. As the VR ecosystem develops over the coming months, we look forward to inviting even more users to our beta programme in advance of the wider consumer release of our product in 2017."

 

– Ends –

 

For further information:

EVR Holdings plc
Sean Nicolson, Chairman	Tel: +44 (0) 20 7466 5000
Anthony Matchett, Chief Executive Officer	www.EVRHoldings.com
SPARK Advisory Partners Limited (Nominated Adviser)
Neil Baldwin / Sean Wyndham-Quin		Tel: +44 (0) 203 368 3550
		www.sparkadvisorypartners.com
Peterhouse Corporate Finance Limited (Broker)		Tel: +44 (0) 20 7469 0930
Eran Zucker / Lucy Williams		www.pcorpfin.com

 

Media enquiries:

Buchanan
Ben Romney / Jamie Hooper Stephanie Watson / Catriona Flint	Tel: +44 (0) 20 7466 5000
EVR@buchanan.uk.com	www.buchanan.uk.com

 

Notes to Editors:

 

MelodyVR

MelodyVR is a wholly owned subsidiary of EVR Holdings plc ('EVR'), a company that is listed on the AIM market of the London Stock Exchange under the ticker EVRH.L. EVR, a creator of virtual reality content, joined AIM on 16 May 2016 following a reverse takeover of Armstrong Ventures plc.

 

The Company has successfully built a VR content library of over 500 globally-renowned artists as well as having secured a number of long-term partnerships, obtaining exclusive recording rights for the creation and distribution of VR content across a total of 50 worldwide event properties and music venues. Further information can be viewed at www.evrholdings.com 

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCLLFFIFTLFFIR

Close

×

RNS Number : 1620S

WANdisco Plc

19 December 2016

 

For immediate release

19 December 2016

 

WANdisco plc

("WANdisco" or the "Company")

 

Significant customer win

 

WANdisco Fusion secures major new customer through IBM partnership

 

WANdisco (LSE: WAND), the leading provider of continuous availability software for global enterprises to meet the challenges of Big Data, is pleased to announce that through its OEM sales partnership with IBM, the Company has secured a significant contract win with a major automotive multinational. The agreement will see IBM deploy the Company's patented cloud solution, WANdisco Fusion, rebranded as IBM Big Replicate, direct to the customer. The agreement is valued at approximately $1m in royalties to be paid to WANdisco.

 

WANdisco Fusion, will be used to ensure customer data is moved seamlessly between data centers and the cloud. It is imperative this is done without any downtime or disruption, and WANdisco Fusion is the only solution capable of delivering this with continuously changing large data sets as the customer moves to self-driving cars, following a major trend transforming the automotive industry.  

 

This deal follows a smaller order with a major European bank that IBM closed on behalf of WANdisco through the OEM sales partnership in Q3 this year, after finalising  the OEM deal in April 2016. In addition, WANdisco has now completed joint product development and has trained over 5,000 quota carrying IBM reps, demonstrating the true scale of this partnership.

 

David Richards, Chief Executive Officer and Interim Chairman of WANdisco, commented:

 

"This is an extremely important contract win for WANdisco which demonstrates our OEM partnership with IBM is capable of delivering significant value for our business. This agreement has been secured on the basis that WANdisco Fusion was the only solution that could ensure complete data consistency without any downtime – which continues to distinguish us from our competitors.

 

"Both WANdisco and IBM continue to develop a significant pipeline of new business opportunities."

 

 

For further information, please contact:

 

WANdisco plc	via Vigo Communications
David Richards, Chief Executive Officer and Interim Chairman
Erik Miller, Chief Financial Officer
Vigo Communications	+44 (0)207 830 9700
Jeremy Garcia / Fiona Henson / Antonia Pollock www.vigocomms.com
Stifel (Joint Broker and Nomad)	+44 (0)207 710 7600
David Arch / Fred Walsh / Neil Shah
UBS (Joint Broker) Rahul Luthra / Sandip Dhillon	+44 (0)207 567 8000

 

About WANdisco

WANdisco (LSE: WAND) is the world leader in Active Transactional Data Replication™. Its patented technology provides continuous consistent access to changing data anytime and anywhere with no downtime and no disruption. WANdisco's patented technology serves crucial high availability (HA) requirements, including migration to cloud, Hadoop Big Data and Application Lifecycle Management (ALM), Subversion, Git and Gerrit.  

 

WANdisco works directly with Fortune 1000 companies around the world and in all sectors to ensure their data, whether it is on-premise or in the cloud, gives them the real insight they need. WANdisco has an OEM with IBM and is also partnered with Amazon Web Services, Cisco, Google Cloud Platform, Hewlett Packard Enterprise, Microsoft Azure and Oracle to resell its patented technology. WANdisco is committed to the ODPi Interoperable Compliance Program to ensure its products are interoperable across a wider range of commercial Apache™ Hadoop® Platforms.

 

For additional information, please visit www.wandisco.com.

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTBRBDDBXBBGLL

Close

×

Neville Registrars is delighted to welcome Al Rayan Bank PLC as the newest addtion to its list of client companies.

Al Rayan Bank is the UK’s only wholly Sharia compliant retail bank. Islamic banking operates without the use of interest and is founded on Islamic finance principles derived from trade, entrepreneurship and risk-sharing.

Further information can be found on the Company's website: https://www.alrayanbank.co.uk/

Close

×

RNS Number : 7736R

Plant Health Care PLC

14 December 2016

 

PLANT HEALTH CARE PLC

 

("Plant Health Care", "PHC" or the "Company")

 

New Commercial Distribution Agreements

Plant Health Care® (AIM: PHC), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce four new commercial distribution arrangements, which together represent important progress in driving sales growth in 2017 and beyond.

 

– Plant Health Care has reached agreement with Talc U.S.A. to launch Inceptive™, a novel product containing PHC's patented Harpin™ 𝜶β technology, which will be mixed with a Talc U.S.A. seed lubricant for corn seed treatment in the USA.  Inceptive has been shown in replicated trials to bring substantial benefits on corn such as improved vigour, heightened defense responses and increased yield.  This agreement will provide PHC with additional access to the 90 million acre corn market in the USA.

 

– Plant Health Care conducted a product demonstration programme, in conjunction with the Florida Fruit & Vegetable Association, to promote the use of PHC's Employ® product (containing PHC's patented Harpin 𝜶β technology), aimed at reducing the impact of fruit drop in the presence of citrus greening, caused by the Huang Long Bing (HLB) bacterium.  This disease has caused devastating damage in citrus in Florida over the last four years, with up to 80% of trees across the state reported as affected.  Use of Employ has been shown in replicated trials to reduce losses by more than 10% in the presence of citrus trees infected by HLB.  Based on these encouraging results, PHC will be distributing Employ in Florida directly with regional distributors. 

 

– Plant Health Care has reached agreement with EDAF Unipessoal LDA, to distribute Plant Health Care's proprietary ProAct® and Myconate® products in Portugal. 

 

– Plant Health Care continues to build on its recent success in South Africa with its Harpin 𝜶β and Myconate products and is now preparing to expand distribution to 23 countries in sub-Saharan Africa through its distribution agreement with DuxAgri (Pty) Ltd.  Plant Health Care is creating significant momentum in the region by concentrating sales to higher value crops, such as sugar cane, vegetables, citrus, pears and macadamia nuts which all receive multiple product applications per year.

 

Dr Chris Richards, Executive Chairman and Interim CEO of Plant Health Care, commented: "Over the last three years, we have steadily built compelling evidence of the efficacy of products based on the Company's patented Harpin technology.  The distribution arrangements announced today reflect further progress in developing sales of the product in significant markets.  We expect that these agreements, together with other projects in progress, will drive strong sales growth of products based on Harpin over the coming years."

 

Enquiries:

 

Plant Health Care plc
Dr Chris Richards, Executive Chairman and Interim CEO
Tel: +44 1837 880083

 

Liberum Capital – Nomad and Broker
Clayton Bush / Chris Clarke
Tel: +44 (0) 20 3100 2000

Company website: www.planthealthcare.com

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

AGRLXLLFQLFFFBE

Close

×

RNS Number : 6346R

Fitbug Holdings PLC

13 December 2016

 

  

Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

 

RNS Reach announcement:

 

Sally Gunnell and Fitbug Corporate Wellness Partnership

 

London, U.K., 13 December 2016 – Fitbug Holdings Plc (FITB), the AIM quoted provider of digital wellness for corporate organisations, today announces a strategic partnership with Olympic gold medallist Sally Gunnell, OBE, to help promote and expand its digital wellness offering to businesses in the UK.

 

Drawing on her professional athletic career, Sally Gunnell and her team of experts have designed a bespoke, highly engaging workplace wellbeing programme that helps companies tackle health and wellness issues among employees. The partnership combines Sally's programme and Fitbug's scalable digital platform to offer a rich corporate health and wellness proposition and to generate new growth opportunities.  

 

Fitbug CEO Anna Gudmundson says; "Sally Gunnell represents great inspiration for positive change and reaching goals, and her brand reflects 'positive energy', which is our brand essence. The extensive knowledge and experience of Sally and her team, together with our highly scalable, engaging and intelligent platforms allows us to offer a well-balanced programme to companies who are serious about their employee wellbeing goals. "

 

Sally Gunnell comments; "I've worked in the corporate market for many years now and research confirms what I know from experience; happy and healthy people are more productive, engaged and successful. Working with Fitbug allows us to reach a much larger audience, and provide a more powerful programme. That way we can have a bigger impact, and create a lasting health legacy within many organisations."

 

Sally Gunnell remains the only woman ever to hold four major track titles concurrently – Olympic, World, European and Commonwealth.  Following her retirement from international athletics, Sally developed a career as a television presenter and motivational speaker.  She has written four books on fitness, health, self-fulfilment and wellbeing.

 

Fitbug is already being used by global corporations to create a positive culture of health, maximise performance, reduce absenteeism and the risk of chronic illness among employees, and lower insurance premiums. Fitbug uses technology and data intelligence to make their solutions scalable, effective and personalised.  

 

 

**ENDS**

 

For further information visit http://landing-pages.fitbug.com/sallygunnell or www.fitbugholdings.com 

 

Contact:

Anna Gudmundson / Donald Stewart	Fitbug Holdings Plc	020 7449 1000
Marc Milmo/ Catherine Leftley	Cantor Fitzgerald Europe, Nomad and Joint Broker	020 7894 7000
Claire Louise Noyce / William Lynne / Niall Pearson	Hybridan LLP, Joint Broker	020 3764 2341
Stephanie Forrest	T/F/D, Public Relations	07917 695755

 

About Fitbug®

Fitbug provides digital wellness solutions that empower employers to create a positive culture of health within their organisation. By helping employees to embrace a healthier way of living, Fitbug can help maximise performance, reduce absenteeism, decrease the risk of chronic illness, and lower healthcare costs.

 

The Company's technological edge allows us to address holistic wellness by engaging both individuals and teams through intelligent, personalised interaction and gamification. This is an opportunity to make incremental behavioural changes that will last a lifetime. The progress of individuals translates to actionable data, meaningful reporting and insights that allow the organisation to monitor the impact of the programme and to refine it in order to achieve success.

 

Fitbug's shares are listed on the London Stock Exchange AIM market under ticker FITB.

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRAEAEAAFSDKFAF

Close